Distinct signatures of the immune responses in low risk versus high risk neuroblastoma

BACKGROUND: Over 90% of low risk (LR) neuroblastoma patients survive whereas less than 30% of high risk (HR) patients are long term survivors. Age (children younger than 18 months old) is associated with LR disease. Considering that adaptive immune system is well developed in older children, and tha...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gowda, Madhu, Godder, Kamar, Kmieciak, Maciej, Worschech, Andrea, Ascierto, Maria-Libera, Wang, Ena, Marincola, Francesco M, Manjili, Masoud H
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2011
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3195752/
https://ncbi.nlm.nih.gov/pubmed/21978632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-170
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller